TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/09/2024
Voltar para busca
Dado oficial do USPTO
AVENIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
54
Atualização mais recente
14/09/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 9
Data de depósito
20/01/2016
Data de registro
24/04/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/10/2023
Última transação
14/09/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/06/2017
Primeiro uso no comércio
01/06/2017
Código do desenho
4
Tipo de titular
03
Localização do titular
Pleasanton, CA
Examinador
GAYNOR, BARBARA
Unidade examinadora
M60
Localização atual
TMO LAW OFFICE 115
Titulares e representantes
Titulares
Roche Molecular Systems, Inc.
Representantes
Mona Gupta Roche Diagnostics Operations, Inc.
Classificação técnica
Classes Nice
Classe 1Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
In vitro diagnostic agentschemical control solutions for calibrating and monitoring the accuracy and function of instruments and test resultschemical additivesenzymesreagentsorganisms and proteins for use in scienceresearch and industry; reagents for cell separation for scientific or research purposes; labeling reagents for scientific or research purposes; reagents for the processingseparationisolationenrichmentdepletiondetectionscreeningcultivationanalysis and counting of materialin particular of chemicals and biological materialall for scientific or research purposes; reagents featuring magnetic beads for scientific or research purposes; antibody reagents for scientific or research purposes; buffer solutions and reagents for use with laboratory apparatusseparation apparatus and analysis apparatusfor scientific or research purposes; reagents for processing biological materialtissuebone marrowcellsblood and components thereof for scientific or research purposes; reagentsenzymesnucleotides for nucleic acid sequencing for scientific or research purposes; diagnostic tests comprised of reagents and chemical test kits for determination of genetic information for scientific or research purposes; reagents for scientific or medical research use for analyzing cellsproteinsnucleic acidssequencing DNAgenotypinggene expression profiling and high through-put screening; reagent kits composed primarily of oligonucleotidesenzymes and buffers for nucleic acid detection in the fields of scientificpharmaceutical and medical research; nucleic acidsenzymesbuffers and chemical reagents for use in genotyping and gene expression test kits for detecting and analyzing nucleic acids for scientific or research purposes; assays and reagents for scientific or medical research use; diagnostic tests and test kits primarily composed of reagents and nucleotides for determination of genetic information for scientific or research purposes; reagents and chemical test kits for scientific and research use in connection with DNA sequencing and genetic analysis
Classe 9
software used for genotyping and gene expression microarrays for scientificpharmaceutical and medical research purposes; software used in analyzingmanaging and visualizing DNA sequencing data; software used for preparation of nucleic acids libraries; computer hardware and software for collectingstoringanalyzing and reporting biological informationfor sample tracking and managing projectslaboratory workflow and datafor use in the fields of scientificdiagnostic and clinical research and for clinical diagnostic purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
54 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/09/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
24/10/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
24/10/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24/10/2023
E815
TEAS SECTION 8 & 15 RECEIVED
25/04/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
24/04/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
19/10/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
19/10/2020
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
19/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19/10/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19/10/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
19/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
27/11/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
27/11/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/10/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/10/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/01/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
24/04/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
22/03/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
21/03/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
01/03/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
28/02/2018
EX3G
SOU EXTENSION 3 GRANTED
28/02/2018
DPCC
DIVISIONAL PROCESSING COMPLETE
28/02/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/02/2018
EXT3
SOU EXTENSION 3 FILED
08/02/2018
EEXT
SOU TEAS EXTENSION RECEIVED
08/02/2018
IUAF
USE AMENDMENT FILED
07/02/2018
DRRR
DIVISIONAL REQUEST RECEIVED
07/02/2018
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
07/02/2018
EISU
TEAS STATEMENT OF USE RECEIVED
07/02/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
15/08/2017
EX2G
SOU EXTENSION 2 GRANTED
11/08/2017
EXT2
SOU EXTENSION 2 FILED
11/08/2017
EEXT
SOU TEAS EXTENSION RECEIVED
11/08/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
25/02/2017
EX1G
SOU EXTENSION 1 GRANTED
23/02/2017
EXT1
SOU EXTENSION 1 FILED
23/02/2017
EEXT
SOU TEAS EXTENSION RECEIVED
23/02/2017
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
23/08/2016
PUBO
PUBLISHED FOR OPPOSITION
28/06/2016
NPUB
NOTICE OF PUBLICATION
08/06/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/05/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/05/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/05/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/05/2016
CNRT
NON-FINAL ACTION MAILED
09/05/2016
CNRT
NON-FINAL ACTION WRITTEN
07/05/2016
DOCK
ASSIGNED TO EXAMINER
04/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/01/2016
NWAP
NEW APPLICATION ENTERED
23/01/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AVENIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.